10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Archives : Old artciles

Wednesday, July 18, 2012

Centenial Surgical Suture Ltd:Buy/sell/growth prospects and recommendation,news and results,target and analysis,view and outlook,multibagger

Scripscan:Centenial Surgical Suture Ltd

Story:Centenial Surgical Suture is in the business of producing all types of surgical sutures used as medical devices in hospitals – it holds body tissues together after an injury or surgery. It is based out of Thane, Maharashtra.Centenial Surgical Suture net profit declined 29.41% to Rs 0.60 crore in the quarter ended March 2012 as against Rs 0.85 crore during the previous quarter ended March 2011. Sales rose 6.28% to Rs 13.87 crore in the quarter ended March 2012 as against Rs 13.05 crore during the previous quarter ended March 2011.For the Unaudited full year,net profit declined 25.48% to Rs 1.55 crore in the year ended March 2012 as against Rs 2.08 crore during the previous year ended March 2011. Sales rose 4.90% to Rs 52.71 crore in the year ended March 2012 as against Rs 50.25 crore during the previous year ended March 2011. It maintains a debt/equity ratio of just under .86, which appears conservative for this type of essential business.This business is subject to risks of lack of funding (probably due to small size), unrestricted imports, increased competition, changes in the regulatory framework (incl Food & Drug Administration rules) etc.There's potential too,if it could capitalize,can touch huge levels.
Source:Aneesh Itty and myself

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner